G

Galapagos NV
D

GLPG

23.870
USD
-0.23
(-0.95%)
Market Open
Volume
1,656
EPS
-1
Div Yield
-
P/E
-1,083
Market Cap
1,572,963,085
OverviewSignalsIdeasNews
Related Instruments
ABBV
ABBV
-3.525
(-1.72%)
201.565 USD
ALNY
ALNY
-10.110
(-3.85%)
252.300 USD
AMGN
AMGN
-2.88
(-0.93%)
310.04 USD
A
ARRY
-0.32000
(-7.26%)
4.09000 USD
C
CRSP
-1.550
(-4.53%)
32.650 USD
G
GLYC
-0.03200
(-14.89%)
0.18290 USD
INCY
INCY
0.180
(0.29%)
62.500 USD
REGN
REGN
-14.36
(-2.30%)
610.88 USD
S
SGMO
0.03780
(6.10%)
0.65790 USD
VRTX
VRTX
5.04
(1.04%)
484.01 USD
More
News
Treasury Yields Decline as Market Anticipates Fed Rate Cuts

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

7 months ago
Economy News
Novo Nordisk Surges in Profit and Sales

Novo Nordisk Surges in Profit and Sales

11 months ago
Stocks News
More

Title: Galapagos NV

Sector: Healthcare
Industry: Biotechnology
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, aBCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.